Related references
Note: Only part of the references are listed.Spotlight on AKT: Current Therapeutic Challenges
Ina Landel et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Precision Targeting of pten-Null Triple-Negative Breast Tumors Guided by Electrophilic Metabolite Sensing
Xuyu Liu et al.
ACS CENTRAL SCIENCE (2020)
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer
Joern Weisner et al.
CANCER RESEARCH (2019)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Covalent-Allosteric Inhibitors to Achieve Akt Isoform-Selectivity
Lena Quambusch et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
AKT Inhibition in Solid Tumors With AKT1 Mutations
David M. Hyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins
Marina Riggio et al.
SCIENTIFIC REPORTS (2017)
Tumor microenvironment conditions alter Akt and Na+/H+ exchanger NHE1 expression in endothelial cells more than hypoxia alone: implications for endothelial cell function in cancer
A. K. Pedersen et al.
BMC CANCER (2017)
Covalent Protein Labeling at Glutamic Acids
Pablo Martin-Gago et al.
CELL CHEMICAL BIOLOGY (2017)
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Jean-Baptiste Telliez et al.
ACS CHEMICAL BIOLOGY (2016)
Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
Jean-Marc Lapierre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Covalent-Allosteric Kinase Inhibitors
Joern Weisner et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression
Nicolle M. Linnerth-Petrik et al.
PLOS ONE (2014)
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance
Phillip A. Schwartz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The PDB_REDO server for macromolecular structure model optimization
Robbie P. Joosten et al.
IUCRJ (2014)
Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases
Matt Addie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Towards automated crystallographic structure refinement with phenix.refine
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Akt signalling in health and disease
Ingeborg Hers et al.
CELLULAR SIGNALLING (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
The Akt isoforms are present at distinct subcellular locations
Stacey A. Santi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Proteus in the World of Proteins: Conformational Changes in Protein Kinases
Matthias Rabiller et al.
ARCHIV DER PHARMAZIE (2010)
The Akt kinases Isoform specificity in metabolism and cancer
Eva Gonzalez et al.
CELL CYCLE (2009)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
PI3K/Akt: getting it right matters
T. F. Franke
ONCOGENE (2008)
Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Bα
Stephen J. Mills et al.
ACS CHEMICAL BIOLOGY (2007)
Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips
Juri Rappsilber et al.
NATURE PROTOCOLS (2007)
Ba/F3 cells and their use in kinase drug discovery
Markus Warmuth et al.
CURRENT OPINION IN ONCOLOGY (2007)
Life with a single isoform of Akt: Mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies
Bettina Dummler et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Essential role of protein kinase Bγ (PKBγ/Akt3) in postnatal brain development but not in glucose homeostasis
O Tschopp et al.
DEVELOPMENT (2005)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Exploring biology with small organic molecules
BR Stockwell
NATURE (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/protein kinase B isoforms in insulin actions
T Katome et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Crystal structure of an inactive Akt2 kinase domain
X Huang et al.
STRUCTURE (2003)
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
H Cho et al.
SCIENCE (2001)
Share Paper
